LHRH analogs versus orchidectomy in prostate cancer
Wilking, N.; Rutqvist, L.E.
Lakartidningen 87(16): 1344-1345
1990
ISSN/ISBN: 0023-7205 PMID: 2109815 Document Number: 353564
Document emailed within 1 workday
Related Documents
Bessoule, O.; Le Loët, X.; Deshayes, P. 1988: Importance of analogs of LHRH in the treatment of bone metastasis of cancer of the prostate in 1988 Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(11): 885-887Rubio Herrera, M.A.; Calle Fernández, J.R. 1986: Treatment of carcinoma of the prostate with analogs of LHRH Revista Clinica Espanola 179(8): 407-411
Keizman, D.; Eisenberger, M.A. 2009: LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy? Oncology 23(7): 631-632
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Zhu, B.; Chu, Y.; Chu, J.; Liu, Y. 1990: The direct effects of lhrh and three lhrh analogs on progesterone secretion by early pregnant human luteal cells in vitro Journal of Shanghai Medical University 17(1): 11-14
Agarwal, M.M.; Mandal, A.K.; Khandelwal, N.; Singh, S.K. 2007: Need for measurement of bone mineral density in patients of prostate cancer before and after orchidectomy: role of quantitative computer tomography Journal of the Association of Physicians of India 55: 486-490
Crawford, E.D.; Hou, A.H. 2009: The role of LHRH antagonists in the treatment of prostate cancer Oncology 23(7): 626-630
Debruyne, F.M.; Fernandez del Moral, P.; Geboers, A.D. 1988: LHRH-analogues therapy for metastatic prostate cancer Progress in Clinical and Biological Research 260: 27-39
Wenderoth, U.K.; Jacobi, G.H. 1986: Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin Annales d'Urologie 20(2): 95-97
Baranowska, B. 1984: Clinical use of LHRH analogs Polski Tygodnik Lekarski 39(29-30): 1005-1007
Balmaceda, J.P.; Borrero, C.; Asch, R.H. 1987: Lhrh analogs female contraception Seminars in Reproductive Endocrinology 5(4): 371-380
Smals, A.G. 1985: Clinical significance of LHRH and its analogs Nederlands Tijdschrift Voor Geneeskunde 129(1): 15-20
Wilking, N.; Rutqvist, L.E.; Theve, T. 1988: LHRH analogs--a new treatment in hormone-dependent tumors Lakartidningen 85(8): 620-623
Abbou, C.C.; Lucas, C.; Leblanc, V. 1997: Tolerance and clinical and biological responses during the first 6 months of treatment with 1-month sustained release LHRH agonists leuprolerin and triptolerin in patients with metastatic prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(6): 984-995
Vegesna, V.; O'Kelly, J.; Said, J.; Uskokovic, M.; Binderup, L.; Koeffle, H.Phillip. 2003: Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo Anticancer Research 23(1a): 283-289
Nieschlag, E.; Akhtar, F.B.; Weinbauer, G.F.; Schuermeyer, T.; Michel, E. 1984: Lhrh analogs for male fertility control experiments in monkeys and men Journal of Steroid Biochemistry 20(6 Part B): 1374
Bouchard, P.; Garcia, E. 1987: Comparison of the mechanisms of action of LHRH analogs and steroids in the treatment of endometriosis Contributions to Gynecology and Obstetrics 16: 260-265
Simonin, R.; Nicolino-Peltier, C.; Gainlet, P. 1989: Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. can their use induce osteoporosis? Presse Medicale 18(41): 2023
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2